Correction: Single-cell analysis of oncolytic virotherapy in adult T-cell leukemia/lymphoma 9 de October de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophages 22 de September de 2025 by Journal for ImmunoTherapy of Cancer current issue
Addendum 1: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma 18 de July de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancers 10 de July de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer 7 de July de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkins lymphoma 2 de July de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: Super-high tumor mutational burden predicts complete remission following immunotherapy: from Petos paradox to druggable cancer hallmark 19 de June de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade 19 de June de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma 13 de June de 2025 by Journal for ImmunoTherapy of Cancer current issue
Correction: SPI1+CD68+ macrophages as a biomarker for gastric cancer metastasis: a rationale for combined antiangiogenic and immunotherapy strategies 22 de May de 2025 by Journal for ImmunoTherapy of Cancer current issue